Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Notice of Charter Renewal, 58866 [E6-16464]

Download as PDF 58866 Federal Register / Vol. 71, No. 193 / Thursday, October 5, 2006 / Notices Dated: September 29, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–16455 Filed 10–4–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through September 18, 2008. For information contact Elaine L. Baker, Designated Federal Officer, Disease, Disability, and Injury Prevention and Control Special Emphasis Panel, Centers for Disease Control and Prevention, Management Analysis and Services Office, 1600 Clifton Road, NE., Mailstop E72, Atlanta, Georgia 30333, telephone 404– 498–0090 or fax 404–498–0011. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 25, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–16464 Filed 10–4–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES mstockstill on PROD1PC61 with NOTICES Centers for Disease Control and Prevention Discontinued Publication of Funding Opportunity Announcements The Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of New Procedure. AGENCY: VerDate Aug<31>2005 15:42 Oct 04, 2006 Jkt 211001 Important notice regarding: (1) Discontinued publication of Funding Opportunity Announcements (FOAs) in the Federal Register; and (2) FOA announcement and application submission via Grants.gov. CDC announces plans to publish all FOAs on https://www.grants.gov and accept electronic applications through this site. All application packages will be posted on Grants.gov, as well, utilizing the PHS5161–1 forms for non-research applications and the new form SF 424 Research and Related (R&R) application for research. Grants.gov will feed the form 424 (R&R) packages directly into the Health and Human Services electronic Research Administration Commons for on-line receipt of research applications. As of October 1, 2005, CDC ceased publication of all FOAs in The Federal Register. CDC currently announces these FOAs, also known as Requests for Application (RFAs) and Program Announcements (PAs), via the Grants.gov on-line submission system. Applicants are able to find a synopsis and attachments of the complete text of all CDC grants and cooperative agreements, as well as apply electronically for opportunities, via https://www.Grants.gov. All FOAs will continue to be posted on the CDC Web site (https://www.cdc.gov/od/pgo/ funding/FOAs.htm) and on the NIH Guide (https://grants1.nih.gov/grants/ guide/), for research. The provisions of the Federal Financial Assistance Management Improvement Act of 1999 (Public Law 106–107) and the President’s Management Agenda have led Federal Agencies to simplify Federal financial assistance application requirements and create a single Web site to apply for Federal assistance. Accordingly, Grants.gov (https://www.grants.gov/) has been designated by the Office of Management and Budget (OMB) as the single access point for all grant programs offered by 26 Federal grantmaking agencies. It provides a single interface for agencies to announce their grant opportunities, and for all grant applicants to find and apply for these opportunities. The PHS–5161–1 application package will be posted in Grants.gov for CDC non-research application submissions. A transition from the PHS Form 398 package to the SF 424 (R&R) forms will allow electronic submission of research applications through Grants.gov. Getting Started—Grants.gov and HHS eRA Commons Registration To provide a secure environment, the submission of electronic applications to PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 HHS and CDC will require organizations to register with Grants.gov (https:// www.grants.gov/applicants/ applicants.jsp), and, in addition, for Research Grants, the applicant will also have to register with HHS eRA Commons (https:// commons.era.nih.gov/commons/). Grants.gov registration provides the ability to submit applications electronically to at least 26 Federal grant-making agencies. HHS eRA Commons registration allows tracking of research application status for the potential grantee organization and Principal Investigator. Additional Information Questions regarding this notice should be directed to the Technical Information Management Section (TIMS), Procurement and Grants Office, Centers for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA 30341, Telephone 770–488– 2700, or e-mail address: pgotim@cdc.gov. Dated: September 26, 2006. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention. [FR Doc. E6–16322 Filed 10–4–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Request for Nominations for Nonvoting Members Representing Industry Interests on Public Advisory Panels or Committees AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is requesting nominations for nonvoting industry representatives to serve on the National Mammography Quality Assurance Advisory Committee (NMQAAC) and certain device panels of the Medical Devices Advisory Committee in the Center for Devices and Radiological Health. DATES: Industry organizations interested in participating in the selection of a nonvoting member to represent industry for the vacancies listed in this document must send a letter to FDA by November 6, 2006, stating their interest in the NMQAAC or one or more panels. Concurrently, nomination materials for prospective candidates should be sent to FDA by November 6, 2006. A nominee E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 71, Number 193 (Thursday, October 5, 2006)]
[Notices]
[Page 58866]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-16464]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Notice of Charter Renewal

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Disease, Disability, and Injury 
Prevention and Control Special Emphasis Panel, Centers for Disease 
Control and Prevention, Department of Health and Human Services, has 
been renewed for a 2-year period through September 18, 2008.
    For information contact Elaine L. Baker, Designated Federal 
Officer, Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel, Centers for Disease Control and Prevention, Management 
Analysis and Services Office, 1600 Clifton Road, NE., Mailstop E72, 
Atlanta, Georgia 30333, telephone 404-498-0090 or fax 404-498-0011.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: September 25, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-16464 Filed 10-4-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.